Combinatorial Tumor Immunotherapy MRC, Chonnam National University Medical School, Hwasun-gun, Jeollanam-do, Republic of Korea.
Cancer Genomic Research Institute, Immunology Laboratory, Seoul Song Do Colorectal Hospital, Seoul, Republic of Korea.
PLoS One. 2024 Aug 23;19(8):e0306254. doi: 10.1371/journal.pone.0306254. eCollection 2024.
While computational epitope prediction methods have found broad application, their use, specifically in allergy-related contexts, remains relatively less explored. This study benchmarks several publicly available epitope prediction tools, focusing on the allergenic IgE and T-cell epitopes of Fel d 1, an extensively studied allergen. Using a variety of tools accessible via the Immune Epitope Database (IEDB) and other resources, we evaluate their ability to identify the known linear IgE and T-cell epitopes of Fel d 1. Our results show a limited effectiveness for B-cell epitope prediction methods, with most performing only marginally better than random selection. We also explored the general predictive abilities on other allergens, and the results were largely random. When predicting T-cell epitopes, ProPred successfully identified all known Fel d 1 T-cell epitopes, whereas the IEDB approach missed two known epitopes and demonstrated a tendency to over-predict. However, when applied to a larger test set, both methods performed only slightly better than random selection. Our findings show the limitations of current computational epitope prediction methods in accurately identifying allergenic epitopes, emphasizing the need for methodological advancements in allergen research.
虽然计算表位预测方法已经得到了广泛的应用,但它们在与过敏相关的背景下的应用,特别是在过敏相关的背景下,仍然相对较少被探索。本研究以广泛研究的过敏原 Fel d 1 的过敏 IgE 和 T 细胞表位为研究对象,对几种可通过免疫表位数据库 (IEDB) 和其他资源获取的公开可用的表位预测工具进行了基准测试。我们评估了这些工具识别已知的 Fel d 1 线性 IgE 和 T 细胞表位的能力。我们的研究结果表明,B 细胞表位预测方法的有效性有限,大多数方法的表现仅略优于随机选择。我们还探索了这些工具对其他过敏原的一般预测能力,结果也基本是随机的。在预测 T 细胞表位时,ProPred 成功地识别了所有已知的 Fel d 1 T 细胞表位,而 IEDB 方法则错过了两个已知的表位,且存在过度预测的趋势。然而,当应用于更大的测试集时,这两种方法的表现仅略优于随机选择。我们的研究结果表明,目前的计算表位预测方法在准确识别过敏原表位方面存在局限性,这强调了在过敏原研究中需要进行方法学上的改进。